This week I'll discuss an important paper in systemic sclerosis, the recent SENSCIS trial that compared 150mg nitedanib to placebo. I wind up coming down pretty hard on this drug; I think it's hype has vastly outpaced its utility. Get the paper itself at ebrheum.com and follow me on @ebrheum to give feedback!
Entries from July 2019
E42: SENSCIS - Nintedanib for Systemic Sclerosis ILD
July 25th, 2019 · Comments
Tags: DefaultTag
E41: Rheum4Debate “SLE Pts. on Cytoxan Should Receive Bactrim”
July 18th, 2019 · Comments
Welcome back! This is the second episode of Rheum4Debate, an oxford-style debate show for the field of rheumatology. In this podcast we'll tackle the question of bactrim prophylaxis in patients receiving cyclophosphamide. The motion was:
“Bactrim prophylaxis should be prescribed to all patients with SLE who are receiving cytoxan and over 20mg of prednisone daily”
Dr. Pankti Reid (@panktireid) argued FOR the motion and Dr. Anisha Dua (@anisha_dua) argued AGAINST the motion.
PLEASE be sure to fill out the post debate poll and let us know what you think! You can find it on my twitter account @ebrheum!
Tags: DefaultTag